SURVEILLE-HPV: Evaluation of HPV16 Circulating DNA as Biomarker to Detect the Recurrence, in Order to Improve Post Therapeutic Surveillance of HPV16-driven Oropharyngeal Cancers

NCT05582122 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

420

Enrollment

OTHER

Sponsor class

Conditions

Oropharynx Squamous Cell Carcinoma

Interventions

BIOLOGICAL: HPV16 Ct-DNA dosing

Sponsor

UNICANCER